# XTAMPZA ER
> **NDA208090** · New Drug Application · Sponsor: COLLEGIUM PHARM INC · Approved 2016-04-26
## Drug
- **FDA Application Number:** NDA208090
- **Application type:** New Drug Application
- **Brand name:** XTAMPZA ER
- **Generic name:** OXYCODONE
- **Active ingredients:** OXYCODONE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** COLLEGIUM PHARM INC
- **Manufacturer:** Collegium Pharmaceutical, Inc.
- **First approval:** 2016-04-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208090)
---
*AI Analytics · CC0 1.0*